Why Contraceptive Innovation?

Despite the availability of various contraceptive methods, more than 200 million women in developing countries want to avoid or delay pregnancy yet are not using an effective family planning method. For some of these women, access to contraception is limited. For others, currently available methods do not meet their needs or preferences or are unaffordable. Innovative solutions are needed in the areas of product development, registration, pricing, and introduction to address these barriers.

Join the exchange and become part of the solution!

Visit our resource library for additional information about the need for contraceptive innovation.


A one-stop shop for resources related to contraceptive research and development

The CTI Exchange offers resources about contraceptive research and development, including information about products currently in development, preclinical and clinical research, and opportunities for future investment. This easily searchable resource library also includes information about regulatory requirements, quality assurance standards, intellectual property, and product introduction strategies, as well as tools for advocacy.

View all resources


Featured resources and latest news from the Exchanges blog


Webinar on Safety of Contraceptives for Young People
The Reproductive Health Supplies Coalition is hosting a webinar on Wednesday, March 29 on the safety of contraceptives for young people.

WHO revises guidance on injectable contraceptive use among women ...
The World Health Organization (WHO) continues to monitor the scientific evidence around the topic of whether hormonal contraceptive use increases a woman’s risk of acquiring HIV. A specia...

Calliope, the Contraceptive Pipeline Database
Calliope, the Contraceptive Pipeline Database, provides information on new and future contraceptive products, including long-acting and novel products currently only available in li...

Efficacy of Dot Fertility Window App to be Tested
Researchers have launched a year-long study to measure the efficacy of Dot™, a smart phone app that uses an algorithm to accurately predict a woman’s pregnancy risk for each day of her c...

Webinar on WHO PQ Collaborative Procedure for Accelerated Registr...
Upcoming RHSC webinar will outline the steps in WHO's collaborative procedure to expedite national registration of prequalified healthcare products and avoid obstacles to country-level commo...

Male Contraception Initiative Issues Call for Proposals
The Male Contraception Initiative is offering up to $500,000 in funding over three years to one or more recipients for research to advance the development of a new, reversible male contracep...

Mithra seeks FDA Approval of its New Vaginal Ring
Mithra Pharmaceuticals announced on January 24, 2017 its intention to submit Myring, a combined hormonal contraceptive vaginal ring, for marketing approval in both Europe and the United Stat...

Round 17 Grand Challenge Exploration Awardees Announced
The Bill & Melinda Gates Foundation recently announced its Grand Challenge Exploration Round 17 Contraceptive Discovery and Family Planning Needs/Preferences/Behaviors award winners.

CTI Exchange Adds Two New Global Resources
Two new resources have been added to the CTI Exchange resource library: The Global Competency Framework for Clinical Research and Ready, Set, Launch Country-level Product Launch Planning Gu...

NIAID to Fund MPT Translational Research
A new NIAID funding opportunity focuses on research on multipurpose prevention technologies that could prevent sexually transmitted infections, HIV, and/or unintended pregnancy.

Male Hormonal Contraception: An Informed Step Forward
A recent publication of study data demonstrated the challenges of bringing a male hormonal contraceptive to market. The results were promising, but not enough for the product to proceed.

Keeping Male Contraceptive Research Front and Center
Novel approaches, identification of new genetic targets, and more expansive acceptability research could lead to development of new male contraceptives in our lifetime.


We want you to join the exchange!


The CTI Exchange looks to partners to help generate and share resources. Contact us with your ideas, materials, or questions, or sign up to receive more information. We also encourage you to provide your feedback